GLB-G25

N/A

Report date: 2025/06/11 11:06:29

NME

Base Information

Drug NameGLB-G25

Drug Alias Namechemically modified DNA aptamers targeting p-AXL (MD Anderson Cancer Center)next generation DNA aptamers targeting p-AXL (MD Anderson Cancer Center)phospho-AXL modulators (MD Anderson Cancer Center)GLB-A04GLB-G25

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer

Mechanisms of ActionAXL receptor tyrosine kinase modulators

TargetsAXL receptor tyrosine kinase

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Texas MD Anderson Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer Center

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A